SPF
GILD icon

South Plains Financial’s Gilead Sciences GILD Stock Holding History

South Plains Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.55K Sell
47
-371
-89% -$52K ﹤0.01% 210
2025
Q4 		$51.3K Buy
+418
New +$50.8K 0.03% 175
2025
Q1 		– Sell
-155
Closed -$14.3K – 249
2024
Q4 		$14.3K Buy
+155
New +$14K 0.01% 194

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

South Plains Financial's GILD Position: Q1 2026 in Review

South Plains Financial reduced its Gilead Sciences (GILD) stake by 89% in Q1 2026, selling an estimated $52K and leaving 47 shares worth $6.55K. The position accounts for ﹤0.01% of the portfolio, ranked #210.

South Plains Financial first reported a position in GILD in Q4 2024 and has held it in 3 quarters since. The position peaked at $51.3K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • South Plains Financial held 47 shares of Gilead Sciences worth $6.55K as of Q1 2026.
  • South Plains Financial sold 371 Gilead Sciences shares in Q1 2026, an estimated $52K.
  • Gilead Sciences made up ﹤0.01% of South Plains Financial's portfolio in Q1 2026, its #210 holding.
  • South Plains Financial first reported a position in Gilead Sciences in Q4 2024 and has held it in 3 quarters since.
  • South Plains Financial's Gilead Sciences position peaked at $51.3K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on South Plains Financial's 13F filing for Q1 2026, filed 13 May 2026.